Huaren Pharmaceutical Co.,Ltd.’s Net Profit Rose 11.4% in First Three Quarters of 2023

Huaren Pharmaceutical Co.,Ltd. (华仁药业股份有限公司) (300110.SZ) reported a net profit of 140.7 million yuan in the first three quarters of 2023, up 11.4% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, up 10.1% year-on-year.

At the end of the reporting period, it had 5.2 billion yuan in total assets and 2.5 billion yuan in total liabilities, with a liability-to-asset ratio of 47.5%.